NDARECTALSUPPOSITORY
Approved
Sep 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EMETE-CON (benzquinamide hydrochloride) is a rectal suppository antiemetic approved in 1978 for the prevention and treatment of nausea and vomiting. It is a small-molecule quinolizine derivative that acts as a dopamine antagonist in the chemoreceptor trigger zone. This product represents a legacy antiemetic option from Pfizer's historical portfolio.
LOE Approaching
As a legacy product approaching loss of exclusivity with minimal competitive pressure (30%), this brand faces headwinds and likely operates with a lean team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on EMETE-CON offers limited career progression given the product's LOE-approaching lifecycle and minimal linked job openings. This assignment is best suited for experienced professionals managing legacy portfolios or early-career professionals seeking baseline commercial/regulatory exposure rather than high-growth opportunities.
Brand ManagerField Sales Representative
Worked on EMETE-CON at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.